Celltrion, LisCure working on gut microbiome therapies for Parkinson’s
LisCure Biosciences is teaming up with Celltrion to identify and develop oral therapies targeting the gut microbiome — the population…
Articles by Patricia Inácio, PhD
IntelGenx to test its montelukast oral film for Parkinson’s
IntelGenx has teamed up with a renowned neurologist at the Karolinska Institute, Sweden to conduct a clinical trial on…
Mindfulness meditation may lessen depression
Mindfulness meditation — a mental training of being focused on the present moment without interpretation or judgment — was better…
Phase 2 Trial of KM-819 Recruiting Patients After Promising Safety Data
Increasing doses of KM-819, a potential therapy being developed by Fascinate Therapeutics for Parkinson’s disease, showed a favorable safety…
FGF-1 Safely Easing Parkinson’s Symptoms in Early Trial, Zhittya Reports
FGF-1, Zhittya Genesis Medical’s treatment candidate, appeared safe and effective at improving motor and cognitive function in the first …
Prediabetes Also May Cause Cognitive Decline With Parkinson’s
Both type 2 diabetes and prediabetes — a condition in which blood sugar levels are abnormally high, but not high…
Data Show Patients Have Longer In-hospital Stays After Neck Surgery
Among people undergoing surgery to remove a damaged spinal disc in the neck, those with Parkinson’s disease had significantly…
Changes in Protein Structure May Act as Parkinson’s Biomarkers
Changes in the structure of 76 proteins in the cerebrospinal fluid (CSF) of people with Parkinson’s disease were seen when…
Metabolon, Tracking Parkinson’s Unite to ID Disease Progression
Metabolon is teaming up with Tracking Parkinson’s, the world’s largest long-term study into Parkinson’s disease, to identify…
Novel Motor Test Added to Trial of Highland’s Brain Stimulation Device
Highland Instruments will use its new technology — called the Integrated Motion Analysis Suite or IMAS — to objectively…